Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Unicycive Therapeutics, Inc. (UNCY) had Operating Cash Flow per Share of $-0.07 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.21M |
|
-- |
|
-- |
|
$7.99M |
|
$-7.99M |
|
$8.56M |
|
$0.57M |
|
$0.57M |
|
$0.57M |
|
$0.57M |
|
$0.57M |
|
$0.57M |
|
$-7.99M |
|
$-7.85M |
|
116.82M |
|
123.83M |
|
$0.00 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$27.35M |
|
$0.08M |
|
$0.60M |
|
$27.95M |
|
$16.68M |
|
-- |
|
-- |
|
$16.68M |
|
$11.27M |
|
$11.27M |
|
$11.27M |
|
119.75M |
|
| Cash Flow Statement Financials | |
$-8.90M |
|
$-0.02M |
|
$2.55M |
|
$26.14M |
|
$19.77M |
|
$-6.37M |
|
$0.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.64 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.92M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
5.06% |
|
5.06% |
|
2.04% |
|
5.06% |
|
$0.09 |
|
$-0.07 |
|
|
Operating Cash Flow per Share |
$-0.07 |